Analysts Set Pacira BioSciences, Inc. (NASDAQ:PCRX) PT at $47.40
Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Free Report) have received a consensus recommendation of “Buy” from the ten analysts that are currently covering the firm, Marketbeat Ratings reports. Ten research analysts have rated the stock with a buy rating. The average twelve-month target price among brokerages that have issued ratings on the stock […]
More Stories
Security Council renews Haiti mission mandate, calls for more action against gangs
The UN Security Council on Monday re-authorized the deployment of the Multinational Security Support (MSS) mission to Haiti for 12...
Short Interest in Cascades Inc. (OTCMKTS:CADNF) Increases By 22.2%
Cascades Inc. (OTCMKTS:CADNF – Get Free Report) saw a large increase in short interest in September. As of September 15th,...
Invesco Water Resources ETF (NASDAQ:PHO) Short Interest Update
Invesco Water Resources ETF (NASDAQ:PHO – Get Free Report) saw a significant increase in short interest in the month of...
Brokerages Set The Interpublic Group of Companies, Inc. (NYSE:IPG) Price Target at $33.00
The Interpublic Group of Companies, Inc. (NYSE:IPG – Get Free Report) has been assigned an average recommendation of “Hold” from...
Enerflex Ltd. (TSE:EFX) Receives Average Rating of “Moderate Buy” from Brokerages
Enerflex Ltd. (TSE:EFX – Get Free Report) has received an average recommendation of “Moderate Buy” from the ten brokerages that...
Ross Stores, Inc. (NASDAQ:ROST) Receives Consensus Rating of “Moderate Buy” from Analysts
Shares of Ross Stores, Inc. (NASDAQ:ROST – Get Free Report) have received a consensus rating of “Moderate Buy” from the...